RT Journal Article SR Electronic T1 DNA Repair Gene ERCC2, XPC, XRCC1, XRCC3 Polymorphisms and Associations with Bladder Cancer Risk in a French Cohort JF Anticancer Research JO Anticancer Res FD International Institute of Anticancer Research SP 1853 OP 1856 VO 28 IS 3B A1 LUC FONTANA A1 RÉMY BOSVIEL A1 LAETITIA DELORT A1 LAURENT GUY A1 NASSÉRA CHALABI A1 FABRICE KWIATKOWSKI A1 SAMIR SATIH A1 NADÈGE RABIAU A1 JEAN-PAUL BOITEUX A1 ALAIN CHAMOUX A1 YVES-JEAN BIGNON A1 DOMINIQUE J. BERNARD-GALLON YR 2008 UL http://ar.iiarjournals.org/content/28/3B/1853.abstract AB In polygenic diseases, association studies look for genetic variation such as polymorphisms in low penetrance genes, i.e. genes in interaction with environmental factors. DNA repair systems that protect the genome from deleterious endogenous and exogenous damage have been shown to significantly reduce activity. In particular, enzymes of the nucleotide excision repair pathway are suspected to be implicated in cancer. In this study bladder cancer which is viewed as a polygenic disease was investigated. The functional polymorphisms of four DNA repair genes, excision repair cross-complementing group 2 (ERCC2), Xeroderma Pigmentosum group C (XPC), and X-ray repair cross-complementing groups 1 and 3 (XRCC1 and XRCC3) were analyzed. The studied population included 51 bladder cancer cases and 45 controls. The genotyping of six SNP (single nucleotide polymorphism) was carried out on these populations with the MGB (Minor Groove Binder) probe technique which uses allelic discrimination with the Taqman® method. The Gln allele of the XPC 939 polymorphism was found to be associated with an increase in bladder cancer risk. Copyright© 2008 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved